News & Articles

Reveal Biosciences Joins the CellCarta Family

CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences MONTREAL, Canada, May 11th, 2021 / CNW – CellCarta, a global provider of precision medicine services, announced today the acquisition

➞ Read More

Validation of a NASH Mouse Model – White Paper

Validation of an Off-the-Shelf, Diet-Induced NASH Mouse Model using Digital Whole Slide Scanning of Liver Tissue and Artificial Intelligence-Enabled, Quantitative Histopathological Analysis Download the PDF White Paper Summary: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic

➞ Read More

Pathology Revealed

Sign up to receive updates on the latest AI-powered pathology breakthroughs, access digital pathology resources, and more.